ORGANOBALANCE GmbH is part of NOVOZYMES A/S since September 2016.


Nature offers numerous opportunities to improve the well-being of humans, animals and the environment. Here at ORGANOBALANCE we have specialized in research and development around the natural diversity of microorganisms. We explore the vast potential of microorganisms for the development of highly innovative and natural compounds and products for the fields of food, feed, personal care, agriculture, the chemical and the pharmaceutical industry.

Furthermore, we contribute to the solution of future challenges of modern society through the development of efficient production microorganisms for the synthesis of valuable compounds. We use our scientific and technical expertise and ingenuity to design sustainable solutions.

ORGANOBALANCE works as service partner, in exclusive partnerships with companies from various industry segments, and out-licenses proprietary product developments.


14 September 2017
What probiotics promise and can achieve
Prof. Dr. Christine Lang at the Microbiome Congress in Heidelberg
- Press release

26 June 2017
Organobalance will present results on probiotics at the 2017 ISAPP conference
- Press release

15 June 2017
Positive Effect of Bacteria: Germfree Isn’t Good.
Prof. Christine Lang interviewed by “Brigitte” magazine
- Press release